Urteste S.A. (WSE:URT)
Poland · Delayed Price · Currency is PLN 42.80
0.00 (0.00%)
Sep 25, 2026, 11:54 AM CET
Urteste Market Cap
Urteste has a market cap or net worth of 65.32 million as of September 24, 2026. Its market cap has decreased by -0.57% in one year.
Market Cap
65.32M
Enterprise Value
62.33M
Revenue
2.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
42.80
ChartMarket Cap Chart
Since October 27, 2021, Urteste's market cap has decreased from 110.64M to 65.32M, a decrease of -40.96%. That is a compound annual growth rate of -10.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 65.32M | 18.81% |
| Dec 30, 2025 | 54.98M | -59.03% |
| Dec 30, 2024 | 134.20M | -12.66% |
| Dec 29, 2023 | 153.65M | 70.57% |
| Dec 30, 2022 | 90.08M | -17.62% |
| Dec 30, 2021 | 109.35M | -1.16% |
| Oct 27, 2021 | 110.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 605.80M |
| Captor Therapeutics Spolka Akcyjna | 443.47M |
| Bioceltix | 413.81M |
| Ryvu Therapeutics | 368.07M |
| BIOTON | 300.52M |
| Synthaverse | 217.46M |
| Molecure | 148.75M |
| Mabion | 125.74M |